Searchable abstracts of presentations at key conferences in endocrinology

ea0073oc9.2 | Oral Communications 9: Endocrine-Related Cancer | ECE2021

Utility of In1-ghrelin as a novel non-invasive diagnostic and prognostic biomarker of prostate cancer in patients with PSA in the grey-zone

Montero-Hidalgo Antonio J. , Herrero-Aguayo Antonio J. , Enrique Gómez-Gómez , Guler Ipek , Justo P. Castaño , Sarmento-Cabral André , Gahete Ortiz Manuel , Luque Raul M , Jiménez Vacas Juan Manuel

Prostate cancer (PCa) is one of the leading causes of cancer deaths among men population worldwide. This tumour pathology is commonly diagnosed through the determination of serum PSA levels. However, the diagnostic capability of PSA dramatically drops when considering patients with PSA levels lower than 10 ng/ml, the so-called “grey-zone”1. Therefore, additional non-invasive diagnostic biomarkers are urgently needed to substitute/complement PSA. In this se...

ea0073oc13.5 | Oral Communications 13: Pituitary and Neuroendocrinology | ECE2021

Potential therapeutic role of somatostatin and cortistatin in prostate cancer

Gomez Jesus Perez , Sáez-Mart Prudencio , Jiménez-Vacas Juan M. , Herrero-Aguayo nez-Vacas> , Pedraza-Arévalo Sergio , Enrique Gómez-Gómez , León-González Antonio J. , Martínez-Fuentes Antonio J. , Castaño Antonio J. , Gahete Manuel D. , Luque Raúl M.

Somatostatin (SST), Cortistatin (CORT), Neuronostatin (NST) and their receptors [SST/CORT-receptors (sst1–5/sst5TMD4-TMD5) and NST-receptor (GPR107)] comprise a hormonal pleiotropic system involved in the regulation of multiple pathophysiological functions. Certain components of this system are dysregulated in endocrine-related cancers, including prostate cancer (PCa), wherein we have found that alterations in specific components of this regulatory system [i.e. NST-GPR10...

ea0073yi6 | Young Investigator Awards | ECE2021

Unveiling the pathophysiological relationship between prostate cancer and obesity: miR-107 as a novel personalized diagnostic and therapeutic tool

Prudencio Sáez-Martínez , Vicente Herrero-Aguayo , Juan M. Jiménez-Vacas , Trinidad Moreno-Montilla , Julia Carrasco-Valiente , André Sarmento-Cabral , José López-Miranda , Enrique Gómez-Gómez , Manuel D. Gahete , Raúl M. Luque

Prostate cancer (PCa) is one of the most common causes of cancer-related deaths in men worldwide. Therefore, more specific and non-invasive diagnostic biomarkers as well as novel therapeutic targets are urgently needed. As miRNAs have been proposed as promising elements for the identification of novel diagnostic and therapeutic tools for different pathologies, including cancer, we investigated the miRNA landscape in PCa and explored their putative diagnostic/therapeutic utilit...

ea0073aep384 | Endocrine-Related Cancer | ECE2021

Oncogenic role of splicing factor SRSF2/SC35 in pancreatic and prostate adenocarcinomas

Berbel Inmaculada , Alors-Perez Emilia , Juan M Jiménez-Vacas , Ricardo Blázquez-Encinas , Cristina Viyuela-García , Álvaro Arjona-Sanchez , Juan Manuel Sánchez-Hidalgo , Marina Sánchez-Frías , Enrique Gómez-Gómez , Ortiz Manuel Gahete , Alejandro Ibañez Costa , Luque Raul M. , Justo P. Castaño

IntroductionAlternative splicing allows the generation of multiple RNA isoforms from a single pre-RNA molecule, and thereby contributes to a multitude of physiological processes, but can also be involved in many diseases, including cancer. Indeed, disruption of alternative splicing has been linked to key cancer features, such as tumor growth, metastasis and hormone responsiveness and is increasingly regarded as a novel and transversal cancer hallmark. Th...

ea0073aep397 | Endocrine-Related Cancer | ECE2021

Anticancer activity of hydroxytyrosol and five semisynthetic lipophilic derivatives in prostate cancer cells

Antonio J. León-González , Prudencio Sáez-Martínez , Juan M. Jiménez-Vacas , Herrero-Aguayo Vicente , Antonio J. Montero-Hidalgo , Enrique Gómez-Gómez , Andrés Madrona , Justo P. Castaño , José L. Espartero , Gahete Manuel D. , Raúl M. Luque

Prostate cancer (PCa) is the second most diagnosed cancer type and the sixth cause of cancer death among men worldwide. Due to the usual slow course of the progression of this disease, there is a growing interest in finding chemopreventive therapeutics with a low risk of side effects. In line with this, recent studies have shown that hydroxytyrosol (HT), one of the main extra virgin olive oil phenolic compounds, exerts a protective role against different cancer types. Moreover...